DEEANNA WILSON: Open Payments
NPI 1093293177 · MURPHY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,474 in 99 payments from 16 companies in 2025. Trend: 2023 $478 · 2024 $992 · 2025 $1,474
Food & beverage: $1,474
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $364 |
| AstraZeneca Pharmaceuticals LP | 12 | $254 |
| Axsome Therapeutics, Inc. | 8 | $182 |
| PFIZER INC. | 14 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $116 |
| Novo Nordisk Inc | 5 | $85 |
| GlaxoSmithKline, LLC. | 3 | $71 |
| Lilly USA, LLC | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Corium, LLC | 4 | $34 |
Products named: VRAYLAR, Auvelity, NURTEC ODT, BREZTRI, CAPLYTA, AIRSUPRA, TRELEGY ELLIPTA, QULIPTA.
Industry payments across NC — which companies pay providers there.
